A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002746:Chlorpromazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003989:Dibenzoxazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013386:Succinates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014149:Tranquilizing Agents
D003989:Dibenzoxazepines; D010879:Piperazines; D010919:Placebos; D013386:Succinates; D014149:Tranquilizing Agents; D002746:Chlorpromazine